TNF and pyoderma gangrenosum: However, some of these drugs, such as the anti-TNF-α agents (e.g., infliximab) and the IL-12/23 inhibitor ustekinumab, have been used successfully in other neutrophilic dermatoses, such as pyoderma gangrenosum [97].